StockData
Milestone Pharmaceuticals Inc. logo

Milestone Pharmaceuticals Inc. (MIST) stock

MISTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.41+0.05 (+13.21%)

Close on Nov 17, 2026Market cap $51.44MP/E –Yield –

Milestone Pharmaceuticals operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Milestone Pharmaceuticals's operating income for the twelve months ending Jun 30, 2026 was -$78.38M. For fiscal 2025 it was -$62.14M. The highest annual figure on record is -$23.82M in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$62.14M–
FY2024Dec 31, 2024-$42.10M–
FY2023Dec 31, 2023-$61.10M–
FY2022Dec 31, 2022-$59.64M–
FY2021Dec 31, 2021-$43.07M–
FY2020Dec 31, 2020-$50.71M–
FY2019Dec 31, 2019-$57.88M–
FY2018Dec 31, 2018-$23.82M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$25.63M–
Q1 FY2026Mar 31, 2026-$23.66M–
Q4 FY2025Dec 31, 2025-$17.26M–
Q3 FY2025Sep 30, 2025-$11.83M–
Q2 FY2025Jun 30, 2025-$12.53M–
Q1 FY2025Mar 31, 2025-$20.52M–
Q4 FY2024Dec 31, 2024-$12.35M–
Q3 FY2024Sep 30, 2024-$9.62M–
Q2 FY2024Jun 30, 2024-$9.66M–
Q1 FY2024Mar 31, 2024-$10.48M–
Q4 FY2023Dec 31, 2023-$13.80M–
Q3 FY2023Sep 30, 2023-$15.36M–
Q2 FY2023Jun 30, 2023-$16.44M–
Q1 FY2023Mar 31, 2023-$15.50M–
Q4 FY2022Dec 31, 2022-$13.76M–
Q3 FY2022Sep 30, 2022-$15.03M–
Q2 FY2022Jun 30, 2022-$16.81M-2460.4%
Q1 FY2022Mar 31, 2022-$14.05M–
Q4 FY2021Dec 31, 2021-$16.92M–
Q3 FY2021Sep 30, 2021-$14.27M–
Q2 FY2021Jun 30, 2021$712.00K–
Q1 FY2021Mar 31, 2021-$12.59M–
Q4 FY2020Dec 31, 2020-$8.76M–
Q3 FY2020Sep 30, 2020-$12.09M–
Q2 FY2020Jun 30, 2020-$13.11M–
Q1 FY2020Mar 31, 2020-$16.76M–
Q4 FY2019Dec 31, 2019-$18.89M–
Q3 FY2019Sep 30, 2019-$13.73M–
Q2 FY2019Jun 30, 2019-$14.33M–
Q1 FY2019Mar 31, 2019-$10.93M–
Q4 FY2018Dec 31, 2018-$10.11M–
Q3 FY2018Sep 30, 2018-$5.79M–
Q2 FY2018Jun 30, 2018-$3.68M–
Q1 FY2018Mar 31, 2018-$4.26M–

More Milestone Pharmaceuticals figures

See a number that looks wrong?